 |
Papillomavirus Vaccines
Research News and Information
Definition of 'Papillomavirus Vaccines'Vaccines or candidate vaccines used to prevent PAPILLOMAVIRUS INFECTIONS. Human vaccines are intended to reduce the incidence of UTERINE CERVICAL NEOPLASMS, so they are sometimes considered a type of CANCER VACCINES. They are often composed of CAPSID PROTEINS, especially L1 protein, from various types of ALPHAPAPILLOMAVIRUS. Common names: Papillomavirus Vaccines; Vaccines, Papillomavirus; Human Papillomavirus Vaccines; Papillomavirus Vaccines, Human; Vaccines, Human Papillomavirus; Human Papilloma Virus Vaccines; HPV Vaccines |
Sunday, November 22, 2009
13 Nov 2009 
The aim of this study was to determine the proportion of invasive cervical cancers attributable to human papillomavirus (HPV) types 16 and 18 in a contemporary, cytologically well-screened UK population. This was achieved in a retrospective ... Read more...
EUROGIN 2008 roadmap on cervical cancer prevention.
13 Nov 2009 The EUROGIN 2008 Roadmap represents a continuing effort to provide updated information on primary and secondary prevention of cervical cancer. The report addresses several areas including the progress made toward global implementation of currently ... Read more...
Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia.
3 Nov 2009 BACKGROUND: Vulvar intraepithelial neoplasia is a chronic disorder caused by high-risk types of human papillomavirus (HPV), most commonly HPV type 16 (HPV-16). Spontaneous regression occurs in less than 1.5% of patients, and the rate of recurrence ... Read more...
Latest indexed articles for 'Papillomavirus Vaccines'
These are the very latest articles for this heading:
- The potential impact of human papillomavirus vaccination in contemporary cytologically screened populations may be underestimated: an observational retrospective analysis of invasive cervical cancers. 13 Nov 2009
- EUROGIN 2008 roadmap on cervical cancer prevention. 13 Nov 2009
- Human papillomavirus vaccine for cancer prevention.
3 Nov 2009 - Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. 3 Nov 2009
- A randomized, placebo-controlled, dose-escalation study to determine the safety, tolerability, and immunogenicity of an HPV-16 therapeutic vaccine in HIV-positive participants with oncogenic HPV infection of the anus. 30 Oct 2009
- Population dynamics of serologically identified coinfections with human papillomavirus types 11, 16, 18 and 31 in fertile-aged Finnish women. 30 Oct 2009
- Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. 30 Oct 2009
- Screening and prevention methods for cervical cancer. 26 Oct 2009
- Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States. 18 Oct 2009
- Summaries for patients. Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States. 18 Oct 2009
- HPV vaccination. 13 Oct 2009
- HPV vaccination in women aged 24-45 years. 8 Oct 2009
- HPV vaccination in women aged 24-45 years. 8 Oct 2009
- Human papillomavirus knowledge and awareness among undergraduates in healthcare training in New Zealand. 7 Oct 2009
- Should HPV vaccine be given to men? 6 Oct 2009
- Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States. 6 Oct 2009
- Cervarix: definitely not the new MMR. 5 Oct 2009
- A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study. 4 Oct 2009
- Taking the service to the young people: a study and analysis of a clinic specifically set up for HPV vaccination provision. 29 Sep 2009
- Teenager who died after having HPV vaccine had a malignant chest tumour. 29 Sep 2009
See a longer list of these articles.
Technical information about 'Papillomavirus Vaccines'
Definition: Vaccines or candidate vaccines used to prevent PAPILLOMAVIRUS INFECTIONS. Human vaccines are intended to reduce the incidence of UTERINE CERVICAL NEOPLASMS, so they are sometimes considered a type of CANCER VACCINES. They are often composed of CAPSID PROTEINS, especially L1 protein, from various types of ALPHAPAPILLOMAVIRUS.
Registry Number: 0
Descriptor UI: D053918
Alternative terms: Papillomavirus Vaccines; Vaccines, Papillomavirus; Human Papillomavirus Vaccines; Papillomavirus Vaccines, Human; Vaccines, Human Papillomavirus; Human Papilloma Virus Vaccines; HPV Vaccines;
Related Mesh Headings: Cancer Vaccines;
Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;
Tree Number: D20.215.894.899.498;
History Note: 2007